How FDA’s New Real-World Data Guidance Solves 3 Big Problems
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically, w...